| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 12 | 2024 | 485 | 1.320 |
Why?
|
| Intellectual Disability | 19 | 2024 | 1042 | 1.200 |
Why?
|
| Abnormalities, Multiple | 18 | 2022 | 964 | 0.810 |
Why?
|
| Phenotype | 24 | 2024 | 4228 | 0.670 |
Why?
|
| De Lange Syndrome | 4 | 2023 | 44 | 0.600 |
Why?
|
| Developmental Disabilities | 12 | 2023 | 699 | 0.540 |
Why?
|
| Chromosomes, Human, X | 3 | 2012 | 157 | 0.530 |
Why?
|
| Facies | 6 | 2021 | 155 | 0.500 |
Why?
|
| Mutation | 15 | 2023 | 5773 | 0.490 |
Why?
|
| Microcephaly | 7 | 2023 | 328 | 0.460 |
Why?
|
| Transcription Factors | 11 | 2023 | 2585 | 0.430 |
Why?
|
| Movement Disorders | 3 | 2023 | 221 | 0.430 |
Why?
|
| Genetic Association Studies | 6 | 2023 | 761 | 0.420 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2012 | 16 | 0.400 |
Why?
|
| Mutation, Missense | 8 | 2023 | 847 | 0.400 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2012 | 71 | 0.390 |
Why?
|
| Chromosome Deletion | 8 | 2014 | 638 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 16 | 5 | 2018 | 150 | 0.380 |
Why?
|
| Craniofacial Abnormalities | 7 | 2021 | 244 | 0.370 |
Why?
|
| DNA Copy Number Variations | 6 | 2018 | 941 | 0.330 |
Why?
|
| Histones | 2 | 2024 | 526 | 0.330 |
Why?
|
| Cerebellar Neoplasms | 1 | 2012 | 282 | 0.320 |
Why?
|
| Medulloblastoma | 1 | 2012 | 338 | 0.320 |
Why?
|
| Nuclear Proteins | 6 | 2023 | 1265 | 0.310 |
Why?
|
| Child | 33 | 2024 | 24241 | 0.300 |
Why?
|
| Child, Preschool | 28 | 2024 | 13888 | 0.290 |
Why?
|
| Myotonic Dystrophy | 2 | 2007 | 145 | 0.290 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 3084 | 0.270 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2006 | 35 | 0.270 |
Why?
|
| Acrocephalosyndactylia | 1 | 2006 | 22 | 0.270 |
Why?
|
| Genetic Variation | 3 | 2021 | 1480 | 0.260 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2018 | 89 | 0.260 |
Why?
|
| Male | 48 | 2024 | 60118 | 0.260 |
Why?
|
| Haploinsufficiency | 4 | 2023 | 247 | 0.250 |
Why?
|
| Mosaicism | 3 | 2022 | 240 | 0.250 |
Why?
|
| Myotonin-Protein Kinase | 3 | 2020 | 40 | 0.250 |
Why?
|
| Homozygote | 1 | 2007 | 533 | 0.250 |
Why?
|
| Cell Cycle Proteins | 3 | 2023 | 644 | 0.250 |
Why?
|
| Humans | 67 | 2024 | 123224 | 0.240 |
Why?
|
| Adolescent | 25 | 2024 | 19110 | 0.240 |
Why?
|
| Chromosome Aberrations | 4 | 2022 | 614 | 0.240 |
Why?
|
| Sequence Deletion | 3 | 2016 | 527 | 0.230 |
Why?
|
| Infant | 22 | 2021 | 12350 | 0.210 |
Why?
|
| Female | 48 | 2024 | 65550 | 0.210 |
Why?
|
| Exons | 3 | 2017 | 794 | 0.210 |
Why?
|
| Gene Duplication | 5 | 2015 | 358 | 0.210 |
Why?
|
| Glypicans | 2 | 2013 | 39 | 0.210 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 12 | 0.210 |
Why?
|
| Prader-Willi Syndrome | 1 | 2023 | 67 | 0.200 |
Why?
|
| Micrognathism | 1 | 2022 | 65 | 0.200 |
Why?
|
| Infant, Newborn | 19 | 2021 | 8108 | 0.200 |
Why?
|
| Malformations of Cortical Development | 1 | 2022 | 53 | 0.200 |
Why?
|
| Hand Deformities, Congenital | 1 | 2022 | 89 | 0.200 |
Why?
|
| Glutamate-tRNA Ligase | 1 | 2021 | 1 | 0.190 |
Why?
|
| Gene Rearrangement | 3 | 2019 | 326 | 0.190 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2020 | 13 | 0.180 |
Why?
|
| Exome | 4 | 2020 | 1041 | 0.180 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 54 | 0.180 |
Why?
|
| Holoprosencephaly | 3 | 2009 | 23 | 0.180 |
Why?
|
| Heterozygote | 4 | 2020 | 672 | 0.180 |
Why?
|
| Histone Acetyltransferases | 1 | 2021 | 313 | 0.180 |
Why?
|
| Mental Disorders | 3 | 2015 | 821 | 0.180 |
Why?
|
| Epilepsy | 3 | 2021 | 858 | 0.180 |
Why?
|
| Hepatoblastoma | 1 | 2022 | 178 | 0.170 |
Why?
|
| Cataract | 2 | 2004 | 218 | 0.170 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2019 | 28 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 245 | 0.170 |
Why?
|
| Comparative Genomic Hybridization | 8 | 2016 | 574 | 0.170 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 113 | 0.170 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 11 | 0.170 |
Why?
|
| Genotype | 8 | 2021 | 2542 | 0.170 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2019 | 18 | 0.160 |
Why?
|
| Cockayne Syndrome | 2 | 2004 | 7 | 0.160 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2019 | 28 | 0.160 |
Why?
|
| Cohort Studies | 9 | 2021 | 4710 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 262 | 0.160 |
Why?
|
| Histone Deacetylases | 2 | 2023 | 114 | 0.160 |
Why?
|
| INDEL Mutation | 1 | 2019 | 88 | 0.160 |
Why?
|
| Genome, Human | 3 | 2017 | 1268 | 0.150 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 389 | 0.150 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 105 | 0.150 |
Why?
|
| Muscle Hypotonia | 1 | 2019 | 185 | 0.150 |
Why?
|
| Noonan Syndrome | 1 | 2018 | 29 | 0.150 |
Why?
|
| Arginine | 1 | 2019 | 303 | 0.150 |
Why?
|
| Nephrosis | 1 | 2017 | 4 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2008 | 139 | 0.150 |
Why?
|
| Actins | 1 | 2019 | 341 | 0.140 |
Why?
|
| Language Development Disorders | 2 | 2017 | 173 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2019 | 214 | 0.140 |
Why?
|
| Adult | 21 | 2024 | 29072 | 0.140 |
Why?
|
| Hernia, Hiatal | 1 | 2017 | 54 | 0.140 |
Why?
|
| Urogenital Abnormalities | 2 | 2021 | 168 | 0.140 |
Why?
|
| Genomic Instability | 1 | 2018 | 229 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2017 | 115 | 0.140 |
Why?
|
| Genomic Imprinting | 2 | 2016 | 123 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 207 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2011 | 85 | 0.130 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2016 | 100 | 0.130 |
Why?
|
| Syndrome | 6 | 2023 | 1115 | 0.130 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2015 | 15 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 459 | 0.130 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2015 | 5 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2016 | 105 | 0.130 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 134 | 0.120 |
Why?
|
| Pierre Robin Syndrome | 1 | 2015 | 29 | 0.120 |
Why?
|
| Translocation, Genetic | 2 | 2022 | 352 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2017 | 1019 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2011 | 1012 | 0.120 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 54 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2021 | 2696 | 0.120 |
Why?
|
| Pedigree | 5 | 2018 | 1584 | 0.120 |
Why?
|
| Frameshift Mutation | 4 | 2020 | 175 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 79 | 0.120 |
Why?
|
| Otx Transcription Factors | 1 | 2014 | 20 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2023 | 810 | 0.120 |
Why?
|
| Young Adult | 9 | 2021 | 8865 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 352 | 0.120 |
Why?
|
| Cranial Fontanelles | 1 | 2014 | 5 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 162 | 0.110 |
Why?
|
| Hypertelorism | 1 | 2014 | 11 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2014 | 119 | 0.110 |
Why?
|
| Gigantism | 1 | 2013 | 14 | 0.110 |
Why?
|
| Saccule and Utricle | 1 | 2013 | 12 | 0.110 |
Why?
|
| Genes, X-Linked | 1 | 2014 | 59 | 0.110 |
Why?
|
| Gene Dosage | 1 | 2015 | 441 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2023 | 554 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 448 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 65 | 0.110 |
Why?
|
| Heart Defects, Congenital | 5 | 2021 | 1806 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 1236 | 0.110 |
Why?
|
| Eye Abnormalities | 1 | 2014 | 106 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2015 | 186 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 306 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 1309 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 2048 | 0.100 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 378 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2022 | 757 | 0.100 |
Why?
|
| Gene Deletion | 4 | 2017 | 793 | 0.100 |
Why?
|
| DNA Mutational Analysis | 5 | 2019 | 793 | 0.090 |
Why?
|
| Inheritance Patterns | 2 | 2009 | 125 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2813 | 0.090 |
Why?
|
| Germ Cells | 2 | 2022 | 192 | 0.090 |
Why?
|
| Tetrasomy | 1 | 2010 | 1 | 0.090 |
Why?
|
| Prostate | 1 | 2013 | 421 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 57 | 0.090 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2010 | 10 | 0.090 |
Why?
|
| Segmental Duplications, Genomic | 4 | 2011 | 81 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2010 | 73 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2010 | 63 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2008 | 396 | 0.090 |
Why?
|
| Sequence Alignment | 4 | 2017 | 623 | 0.090 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2010 | 99 | 0.090 |
Why?
|
| Chromosome Duplication | 1 | 2010 | 147 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2010 | 159 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2023 | 740 | 0.080 |
Why?
|
| Chromosome Disorders | 2 | 2011 | 309 | 0.080 |
Why?
|
| Karyotyping | 3 | 2022 | 330 | 0.080 |
Why?
|
| Trisomy | 2 | 2000 | 103 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 442 | 0.080 |
Why?
|
| Genes, Dominant | 2 | 2007 | 248 | 0.080 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 3868 | 0.080 |
Why?
|
| Scrotum | 2 | 2021 | 23 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2008 | 102 | 0.070 |
Why?
|
| Intracranial Thrombosis | 1 | 2007 | 12 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2009 | 371 | 0.070 |
Why?
|
| Alleles | 4 | 2021 | 1603 | 0.070 |
Why?
|
| Cystine | 1 | 2006 | 15 | 0.070 |
Why?
|
| Animals | 11 | 2021 | 33759 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2010 | 555 | 0.070 |
Why?
|
| Urinary Bladder | 2 | 2019 | 242 | 0.060 |
Why?
|
| Whole Genome Sequencing | 2 | 2017 | 286 | 0.060 |
Why?
|
| Serine | 1 | 2006 | 172 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 356 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 223 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 543 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2018 | 368 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2017 | 834 | 0.060 |
Why?
|
| Mice | 7 | 2021 | 17503 | 0.060 |
Why?
|
| Zebrafish | 2 | 2017 | 386 | 0.060 |
Why?
|
| Blepharophimosis | 2 | 2021 | 26 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2003 | 84 | 0.050 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2023 | 25 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2017 | 1070 | 0.050 |
Why?
|
| Hyperphagia | 1 | 2023 | 46 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 147 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4273 | 0.050 |
Why?
|
| Cleft Palate | 1 | 2005 | 140 | 0.050 |
Why?
|
| Oxytocin | 1 | 2023 | 70 | 0.050 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2002 | 14 | 0.050 |
Why?
|
| Homocystinuria | 1 | 2002 | 21 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 78 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 224 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2020 | 3546 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 326 | 0.050 |
Why?
|
| Autistic Disorder | 2 | 2020 | 346 | 0.050 |
Why?
|
| Pregnancy | 8 | 2015 | 7161 | 0.050 |
Why?
|
| Congenital Hypothyroidism | 1 | 2021 | 6 | 0.050 |
Why?
|
| Psychomotor Disorders | 1 | 2021 | 28 | 0.050 |
Why?
|
| Patella | 1 | 2021 | 29 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 253 | 0.050 |
Why?
|
| Joint Instability | 1 | 2021 | 42 | 0.050 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2021 | 27 | 0.050 |
Why?
|
| Dysostoses | 1 | 2000 | 2 | 0.050 |
Why?
|
| Scapula | 1 | 2000 | 12 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2007 | 809 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2011 | 1081 | 0.050 |
Why?
|
| Acidosis, Lactic | 1 | 2021 | 30 | 0.050 |
Why?
|
| Shoulder | 1 | 2000 | 29 | 0.050 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 66 | 0.040 |
Why?
|
| Chromosome Breakage | 2 | 2011 | 168 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2000 | 93 | 0.040 |
Why?
|
| Pelvis | 1 | 2000 | 68 | 0.040 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2000 | 11 | 0.040 |
Why?
|
| Face | 2 | 2019 | 180 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 426 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 863 | 0.040 |
Why?
|
| Reproduction | 1 | 2002 | 243 | 0.040 |
Why?
|
| Cerebellar Ataxia | 1 | 2020 | 65 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2020 | 277 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2021 | 225 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2021 | 333 | 0.040 |
Why?
|
| Paraganglioma | 1 | 1999 | 19 | 0.040 |
Why?
|
| Codon, Terminator | 1 | 2019 | 26 | 0.040 |
Why?
|
| Hearing Disorders | 1 | 1999 | 25 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 2000 | 68 | 0.040 |
Why?
|
| Stroke | 1 | 2007 | 958 | 0.040 |
Why?
|
| Cornea | 1 | 2004 | 645 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 2586 | 0.040 |
Why?
|
| Megalencephaly | 1 | 2019 | 58 | 0.040 |
Why?
|
| Molecular Biology | 1 | 1999 | 77 | 0.040 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1999 | 62 | 0.040 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1999 | 70 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 142 | 0.040 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 73 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 149 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1998 | 50 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 120 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2018 | 35 | 0.040 |
Why?
|
| White Matter | 1 | 2020 | 181 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 64 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 2058 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 1998 | 113 | 0.040 |
Why?
|
| Middle Aged | 4 | 2020 | 26016 | 0.040 |
Why?
|
| Hearing Loss | 1 | 2019 | 131 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2000 | 262 | 0.040 |
Why?
|
| Kidney | 2 | 2021 | 1337 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2017 | 42 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 1999 | 422 | 0.040 |
Why?
|
| Nephrotic Syndrome | 1 | 2017 | 47 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2017 | 70 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 126 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 101 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 76 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 353 | 0.030 |
Why?
|
| Point Mutation | 1 | 2018 | 348 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 195 | 0.030 |
Why?
|
| Glaucoma | 1 | 1997 | 89 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 408 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 120 | 0.030 |
Why?
|
| Podocytes | 1 | 2017 | 79 | 0.030 |
Why?
|
| Anxiety | 1 | 2023 | 957 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 105 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 223 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2018 | 454 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2017 | 178 | 0.030 |
Why?
|
| Mitochondria | 1 | 2021 | 677 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 76 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 577 | 0.030 |
Why?
|
| Craniosynostoses | 2 | 2013 | 131 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1101 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1995 | 59 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 1477 | 0.030 |
Why?
|
| Cataract Extraction | 1 | 1997 | 210 | 0.030 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 83 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2015 | 55 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 672 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 1999 | 481 | 0.030 |
Why?
|
| Microsatellite Repeats | 3 | 2000 | 219 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 251 | 0.030 |
Why?
|
| Genitalia | 1 | 2014 | 36 | 0.030 |
Why?
|
| Base Sequence | 3 | 2011 | 3091 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 697 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 481 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 579 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 831 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1339 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2015 | 401 | 0.030 |
Why?
|
| Urethral Diseases | 1 | 2013 | 17 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2013 | 59 | 0.030 |
Why?
|
| Cerebellum | 1 | 1997 | 414 | 0.030 |
Why?
|
| Disorders of Sex Development | 1 | 2013 | 78 | 0.030 |
Why?
|
| Penis | 1 | 2013 | 97 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 1998 | 707 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4353 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2022 | 16033 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5049 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 873 | 0.020 |
Why?
|
| Agenesis of Corpus Callosum | 2 | 2004 | 38 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 78 | 0.020 |
Why?
|
| Aged | 2 | 2007 | 19098 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2011 | 36 | 0.020 |
Why?
|
| Growth Disorders | 2 | 2005 | 207 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1781 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 2964 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2009 | 30 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 1695 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 298 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 1529 | 0.020 |
Why?
|
| Radiography | 2 | 2000 | 823 | 0.020 |
Why?
|
| Hirsutism | 1 | 2007 | 19 | 0.020 |
Why?
|
| Protein S | 1 | 2007 | 10 | 0.020 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2007 | 19 | 0.020 |
Why?
|
| Protein C | 1 | 2007 | 21 | 0.020 |
Why?
|
| Prothrombin | 1 | 2007 | 24 | 0.020 |
Why?
|
| Factor V | 1 | 2007 | 17 | 0.020 |
Why?
|
| Family | 1 | 2011 | 578 | 0.020 |
Why?
|
| Antithrombin III | 1 | 2007 | 25 | 0.020 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2007 | 51 | 0.020 |
Why?
|
| Pregnancy Outcome | 2 | 2002 | 600 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 63 | 0.020 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2007 | 70 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1584 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 216 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 79 | 0.020 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2007 | 125 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 294 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 259 | 0.020 |
Why?
|
| Lipoprotein(a) | 1 | 2007 | 114 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2008 | 300 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2010 | 391 | 0.020 |
Why?
|
| Recurrence | 1 | 2009 | 1423 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2007 | 369 | 0.020 |
Why?
|
| Risk Factors | 2 | 2010 | 10015 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1758 | 0.010 |
Why?
|
| Microphthalmos | 1 | 2004 | 60 | 0.010 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2003 | 12 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2003 | 40 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 118 | 0.010 |
Why?
|
| Xenopus | 1 | 2003 | 107 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 204 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 273 | 0.010 |
Why?
|
| Placenta | 1 | 2007 | 493 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 316 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 2406 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2003 | 110 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 462 | 0.010 |
Why?
|
| Homocystine | 1 | 2002 | 3 | 0.010 |
Why?
|
| Pyridoxine | 1 | 2002 | 14 | 0.010 |
Why?
|
| Amino Acids, Sulfur | 1 | 2002 | 15 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2002 | 256 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 1068 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 689 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 2000 | 37 | 0.010 |
Why?
|
| Skin Abnormalities | 1 | 2000 | 32 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 1292 | 0.010 |
Why?
|
| Autopsy | 1 | 2000 | 110 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 766 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 2000 | 48 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2002 | 304 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2000 | 123 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2000 | 176 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 80 | 0.010 |
Why?
|
| Ear, External | 1 | 1999 | 22 | 0.010 |
Why?
|
| Decision Trees | 1 | 1999 | 49 | 0.010 |
Why?
|
| Amino Acids | 1 | 2002 | 658 | 0.010 |
Why?
|
| Lod Score | 1 | 1999 | 120 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2002 | 254 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1999 | 80 | 0.010 |
Why?
|
| Teratogens | 1 | 1999 | 87 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1998 | 70 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 1877 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 105 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1998 | 78 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1998 | 131 | 0.010 |
Why?
|
| Gene Library | 1 | 1998 | 220 | 0.010 |
Why?
|
| Haplotypes | 1 | 1999 | 519 | 0.010 |
Why?
|
| Introns | 1 | 1998 | 302 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1999 | 175 | 0.010 |
Why?
|
| Nipples | 1 | 1997 | 7 | 0.010 |
Why?
|
| Dandy-Walker Syndrome | 1 | 1997 | 11 | 0.010 |
Why?
|
| Corpus Callosum | 1 | 1997 | 98 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2000 | 588 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2003 | 796 | 0.010 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1997 | 122 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 80 | 0.010 |
Why?
|
| CHO Cells | 1 | 1995 | 155 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 1592 | 0.010 |
Why?
|
| Cricetinae | 1 | 1995 | 408 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1999 | 507 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 368 | 0.010 |
Why?
|
| Drosophila | 1 | 1998 | 766 | 0.010 |
Why?
|
| Software | 1 | 1998 | 678 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1999 | 997 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 1593 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1995 | 809 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1995 | 879 | 0.010 |
Why?
|